Department of Pharmacology and Chemistry and Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Vanderbilt University , Nashville, Tennessee 37232-6600, United States.
ACS Chem Neurosci. 2011 Oct 19;2(10):554. doi: 10.1021/cn200084v.
On January 21, 2011, the U.S. Food and Drug Administration approved Viibryd, a new selective serotonin reuptake inhibitor (SSRI), to treat major depressive disorder in adults developed by Clinical Data, Inc.
2011 年 1 月 21 日，美国食品和药物管理局批准了由 Clinical Data, Inc. 开发的新型选择性 5-羟色胺再摄取抑制剂（SSRI）——Viibryd，用于治疗成年人的重度抑郁症。
